Sequent Scientific Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Rajaram Narayanan

Chief Executive Officer (CEO)

₹49.2m

Compensación total

Porcentaje del salario del CEO	100.0%
Permanencia del CEO	2yrs
Participación del CEO	n/a
Permanencia media de la dirección	2yrs
Promedio de permanencia en la Junta Directiva	3.7yrs

Actualizaciones recientes de la dirección

Recent updates

Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

Jan 05

What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Dec 24

Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Dec 12

Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Nov 22

Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

Nov 10

The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

Oct 20

How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Oct 05

Is Sequent Scientific Limited's (NSE:SEQUENT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Sep 04

Do Sequent Scientific's (NSE:SEQUENT) Earnings Warrant Your Attention?

Aug 20

Sequent Scientific Limited's (NSE:SEQUENT) Earnings Haven't Escaped The Attention Of Investors

Jul 30

Does Sequent Scientific (NSE:SEQUENT) Have A Healthy Balance Sheet?

Jul 10

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Rajaram Narayanan en comparación con los beneficios de Sequent Scientific?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	-₹1b
Sep 30 2023	n/a	n/a	-₹1b
Jun 30 2023	n/a	n/a	-₹1b
Mar 31 2023	₹49m	₹49m	-₹1b

Compensación vs. Mercado: La compensación total de Rajaram($USD590.19K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD278.32K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Rajaram con los resultados de la empresa.

CEO

Rajaram Narayanan (55 yo)

2yrs

Permanencia

₹49,170,000

Compensación

Mr. Rajaram Narayanan serves as Managing Director & Chief Executive Officer at Sequent Scientific Limited since April 11, 2022 and also serves as its Director since April 11, 2022. He served as Managing Di...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Rajaram Narayanan	MD, CEO & Director	2yrs	₹49.17m	sin datos
Sharat Narasapur	Joint MD & Director	7.3yrs	₹19.36m	sin datos
Saurav Bhala	Chief Financial Officer	no data	sin datos	sin datos
Ramesh Pillai	Corporate Vice President of Ra Qa and Technical Services	no data	sin datos	sin datos
Ravi Nair	Executive Vice President of Human Resources & Administration	no data	sin datos	sin datos
Abhishek Singhal	Head of Investor Relations	no data	sin datos	sin datos
Phillip Trott	Secretary	less than a year	sin datos	sin datos
Prasad Lad	Vice President of HR & Administration	no data	sin datos	sin datos

2.0yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de SEQUENT se considera experimentado (2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Rajaram Narayanan	MD, CEO & Director	2yrs	₹49.17m	sin datos
Sharat Narasapur	Joint MD & Director	7.3yrs	₹19.36m	sin datos
Neeraj Bharadwaj	Additional Non-Executive & Non-Independent Director	3.7yrs	sin datos	sin datos
Milind Sarwate	Independent Director	3.7yrs	₹2.19m	sin datos
George Gunn	Member of Global Advisory Board	no data	sin datos	sin datos
Kamal Sharma	Independent Chairman	3.7yrs	₹2.09m	sin datos
Ruurd Stolp	Member of Global Advisory Board	no data	sin datos	sin datos
Fabian Kausche	Additional Non-Executive & Non-Independent Director	3.3yrs	₹1.28m	sin datos
Kausalya Santhanam	Independent Non-Executive Director	9.5yrs	₹1.39m	sin datos
Huseyin Aydin	Non-Executive Director of Alivira Animal Health Limited - India	no data	sin datos	sin datos
Gregory Andrews	Additional Non-Executive Non-Independent Director	3.4yrs	₹1.28m	sin datos
Hari Bodepudi	Non Executive Director	less than a year	sin datos	sin datos

3.7yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de SEQUENT se considera experimentada (3.7 años de antigüedad promedio).

Sequent Scientific Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024

Sequent Scientific Limited Announces Executive Changes

Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024

Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer

Sequent Scientific Limited, Annual General Meeting, Aug 30, 2023

Sequent Scientific Limited Announces Resignation of Rahul Mukim as Director

Recent updates

Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024

Third quarter 2024 earnings released: EPS: ₹0.33 (vs ₹0.36 loss in 3Q 2023)

Sequent Scientific Limited Announces Executive Changes

Sequent Scientific Limited to Report Q3, 2024 Results on Feb 13, 2024

Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024

Sequent Scientific Limited to Report Q2, 2024 Results on Nov 06, 2023

Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer

Sequent Scientific Limited, Annual General Meeting, Aug 30, 2023

Sequent Scientific Limited to Report Q1, 2024 Results on Aug 10, 2023

Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra

Full year 2023 earnings released: ₹4.88 loss per share (vs ₹1.67 profit in FY 2022)

Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings released: ₹0.36 loss per share (vs ₹0.69 profit in 3Q 2022)

Sequent Scientific Limited Announces Resignation of Rahul Mukim as Director

Price target decreased to ₹149

High number of new and inexperienced directors

Second quarter 2023 earnings released: ₹0.15 loss per share (vs ₹0.58 profit in 2Q 2022)

Sequent Scientific Limited (BSE:512529) agreed to acquire Tineta Pharma Private Limited from group of shareholders for INR 2.18 billion.

Sequent Scientific Limited to Report Q2, 2023 Results on Nov 14, 2022

Sequent Scientific Limited, Annual General Meeting, Sep 20, 2022

First quarter 2023 earnings released: ₹0.57 loss per share (vs ₹0.04 profit in 1Q 2022)

Sequent Scientific Limited to Report Q1, 2023 Results on Aug 08, 2022

Investor sentiment improved over the past week

Sequent Scientific Limited Appoints P V Raghavendra Rao as the Chief Financial Officer

Investor sentiment deteriorated over the past week

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Sequent Scientific Limited to Report Q4, 2022 Results on May 25, 2022

Price target decreased to ₹170

High number of new and inexperienced directors

Sequent Scientific Limited Announces Resignation of Tushar Mistry Chief Financial Officer, Effective May 31, 2022

Sequent Scientific Limited Announces Resignation of Mr. Manish Gupta from the Position of CEO

Sequent Scientific Limited Announces Appointment of Rajaram Narayanan as Managing Director

CEO, MD & Executive Director recently sold ₹73m worth of stock

Investor sentiment improved over the past week

CEO, MD & Executive Director recently sold ₹84m worth of stock

CEO, MD & Executive Director recently sold ₹23m worth of stock

CEO, MD & Executive Director recently sold ₹27m worth of stock

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to ₹197

Insider recently sold ₹5.7m worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought ₹1.4m worth of stock

Second quarter 2022 earnings released: EPS ₹0.58 (vs ₹0.86 in 2Q 2021)

Investor sentiment deteriorated over the past week

Insider recently sold ₹17m worth of stock

Insider recently sold ₹17m worth of stock

Full year 2021 earnings released: EPS ₹3.87 (vs ₹2.87 in FY 2020)

Insider recently sold ₹1.3m worth of stock

Third quarter 2021 earnings released: EPS ₹1.54 (vs ₹0.83 in 3Q 2020)

New 90-day high: ₹232

Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

Sequent Scientific Limited to Report Q3, 2021 Results on Feb 03, 2021

New 90-day high: ₹215

Investor sentiment improved over the past week

How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?

Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

New 90-day high: ₹181

What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Chief Financial Officer recently sold ₹7.7m worth of stock

Sequent Scientific Limited Appoints Fabian Kausche as an Additional (Non-Executive Non-Independent) Director

Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Insider recently sold ₹8.7m worth of stock

New 90-day high: ₹169

Sequent Scientific Limited Announces Launch of Inhouse Developed Halofusol® in EU

Insider recently sold ₹79m worth of stock

Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Insider recently sold ₹3.8m worth of stock